Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.66 HKD | 0.00% | +1.24% | -50.97% |
Jun. 03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
May. 30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |